Mass Tort Financing

Dupixent Products Liability Litigation: Case & Funding Information

MDL No. 3180 — official JPML data plus plain-English guidance on lawsuit funding for claimants.

Reviewed by Jack King · Last updated 2026-09-23

What This Case Is About

The Dupixent Products Liability Litigation litigation is a federal multidistrict litigation (MDL No. 3180) centralized before Judge Quraishi, Zahid N. in the NJ district. Cases in an MDL share factual questions; each claimant keeps their own case.

Official Docket Data (JPML)

Source: US Judicial Panel on Multidistrict Litigation, pending MDL docket report (July 2026).

Can You Get Lawsuit Funding On This Case?

If you have a pending claim in this litigation and are represented by an attorney, you may qualify for pre-settlement funding. Funding is a cash advance against a possible future settlement — not a loan in the traditional sense, and repayment typically depends on your case outcome.

General criteria: represented by counsel, a filed or eligible claim, and a case with expected value. Every provider evaluates independently.

What To Watch Out For

Lawsuit funding costs vary widely and are regulated differently by state. Compare offers, ask for the full effective rate in writing, and talk to your attorney before signing anything. Funding is optional — never required to keep your case active.

Check If You Qualify — Free Review